Major bleeding risk in atrial fibrillation patients co-medicated with non-vitamin k oral anticoagulants and antipsychotics

HIGHLIGHTS

• who: With Non-Vitamin K Oral and colleagues from the Sapienza University of Rome, Italy have published the research: Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics, in the Journal: (JOURNAL) of 31/Dec/2017
• what: The study demonstrates that atypical anti-psychotics also had a less increased bleeding risk than typical ones when combined with NOAC use. Study Strengths the study has several strengths.
• how: To account for intraindividual correlation across person-quarters the authors used logistic regression with a generalized estimating equations . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.